Steve Elms

Affiliations

  • at Elevation Oncology Inc. (ELEV), 2024-06-17
  • at Adma Biologics Inc. (ADMA), 2024-03-20
  • Director at Marker Therapeutics Inc. (MRKR), 2023-06-09
  • Director at Zosano Pharma Corp (ZSAN), 2021-06-15
  • Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2019-07-15
  • Large Shareholder, Director at Loxo Oncology Inc. (LOXO), 2019-02-15
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Director at Pernix Therapeutics Holdings Inc. (PTX), 2016-05-31
  • Large Shareholder at Viewray Inc. (VRAY), 2016-03-30
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder, Director at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-04-27
  • Director at Cidara Therapeutics Inc. (CDTX), 2015-04-22
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Director at Ambit Biosciences Corp (AMBI), 2014-09-05
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27
  • Large Shareholder at Cempra Inc. (CEMP), 2012-02-09
  • Director at Map Pharmaceuticals Inc. (MAPP), 2010-05-24
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRKR $1.75 1,142,857 Director 3,142,857 2021-03-16 Filing
LOXO $13.00 413,077 Large Shareholder, Director 3,452,493 2014-08-06 Filing
AMBI $8.00 423,635 Director 1,546,444 2013-05-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ADMA $6.08 411,829 2,115,671 2024-03-19 Filing
ADMA $6.01 49,887 2,527,500 2024-03-18 Filing
ADMA $6.01 183,008 2,577,387 2024-03-15 Filing
ADMA $6.05 448,276 2,760,395 2024-03-14 Filing
ADMA $6.21 407,000 3,208,671 2024-03-13 Filing